| # | Title | Journal | Year | Citations |
|---|
| 1 | Rheumatoid arthritis | Best Practice and Research in Clinical Rheumatology | 2010 | 183 |
| 2 | Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial | Journal of Rheumatology | 2001 | 167 |
| 3 | Reliability of Gait Measurements in People With Osteoarthritis of the Knee | Physical Therapy | 1997 | 126 |
| 4 | The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints | Statistical Methods in Medical Research | 2008 | 125 |
| 5 | The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas | Annals of the Rheumatic Diseases | 2005 | 71 |
| 6 | Magnetic resonance imaging in psoriatic arthritis: a review of the literature | Arthritis Research and Therapy | 2006 | 69 |
| 7 | Anti-Nuclear, Anti-Neutrophil Cytoplasmic and Anti-Glomerular Basement Membrane Antibodies in Hiv-Infected Individuals | Autoimmunity | 1994 | 67 |
| 8 | Iterative Development and Reliability of the OMERACT Hand Osteoarthritis MRI Scoring System | Journal of Rheumatology | 2014 | 55 |
| 9 | Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls | Clinical and Experimental Immunology | 2000 | 53 |
| 10 | How many life years are lost in patients with rheumatoid arthritis? Secular cause‐specific and all‐cause mortality in rheumatoid arthritis, and their predictors in a long‐term Australian cohort study | Internal Medicine Journal | 2013 | 53 |
| 11 | Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials | Journal of Rheumatology | 2001 | 52 |
| 12 | Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: Interleukin-17 expression is upregulated in early disease | Clinical and Experimental Immunology | 2001 | 46 |
| 13 | A double blind randomised trial of low power laser treatment in rheumatoid arthritis. | Annals of the Rheumatic Diseases | 1993 | 43 |
| 14 | Antinuclear antibodies using HEp-2 cells in normal children and in children with common infections | Journal of Paediatrics and Child Health | 1991 | 36 |
| 15 | Understanding the dose–response relationship of allopurinol: predicting the optimal dosage | British Journal of Clinical Pharmacology | 2013 | 33 |
| 16 | Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients | Arthritis Research and Therapy | 2012 | 32 |
| 17 | Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis | Seminars in Arthritis and Rheumatism | 2018 | 32 |
| 18 | The power of the protocol | Lancet, The | 2002 | 28 |
| 19 | The Longitudinal Reliability and Responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS) | Journal of Rheumatology | 2015 | 25 |
| 20 | A users guide to measurement in medicine | Osteoarthritis and Cartilage | 2006 | 24 |
| 21 | Foundations of the minimal clinically important difference for imaging | Journal of Rheumatology | 2001 | 24 |
| 22 | Robustness and generalizability of smallest detectable difference in radiological progression | Journal of Rheumatology | 2001 | 24 |
| 23 | Poor accuracy and interobserver reliability of knee arthroscopy measurements are improved by the use of variable angle elongated probes | Annals of the Rheumatic Diseases | 2002 | 20 |
| 24 | Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database | International Journal of Rheumatology | 2009 | 20 |
| 25 | Gait variables: appropriate objective outcome measures in rheumatoid arthritis | British Journal of Rheumatology | 1999 | 19 |
| 26 | RE-EVALUATING THE NEED FOR HOSPITALIZATION FOLLOWING SYNOVECTOMY USING YTTRIUM-90 SILICATE | Rheumatology | 1993 | 17 |
| 27 | Individualising the dose of allopurinol in patients with gout | British Journal of Clinical Pharmacology | 2017 | 17 |
| 28 | Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database | International Journal of Rheumatology | 2009 | 16 |
| 29 | Measurement of HLA class I expression in ankylosing spondylitis. | Annals of the Rheumatic Diseases | 1992 | 11 |
| 30 | Recently characterised autoantibodies and their clinical significance | Australian and New Zealand Journal of Medicine | 1992 | 10 |
| 31 | Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration | Free Radical Biology and Medicine | 2018 | 10 |
| 32 | Better guidelines to rheumatoid arthritis therapy | Australian and New Zealand Journal of Medicine | 1993 | 7 |
| 33 | Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease | Internal Medicine Journal | 2004 | 7 |
| 34 | Reclassification of Antirheumatic Agents | BioDrugs | 1994 | 6 |
| 35 | Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia | Rheumatology | 2022 | 6 |
| 36 | ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN INFLAMMATORY ARTHRITIS—POTENTIAL FOR MISDIAGNOSIS? | Rheumatology | 1995 | 5 |
| 37 | Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis | BMJ Open | 2016 | 5 |
| 38 | Does regular use of non-steroidal anti-inflammatory drugs increase the risk of renal disease? | Nephrology | 2002 | 4 |
| 39 | Imaging: the need for standardization | Best Practice and Research in Clinical Rheumatology | 2008 | 4 |
| 40 | Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk | Journal of Autoimmunity | 2021 | 4 |
| 41 | Evaluation of anti-nuclear antibody tests: A report on the workshop of the australian rheumatism association October 1980 | Pathology | 1981 | 4 |
| 42 | Concordance between myositis autoantibodies and anti-nuclear antibody patterns in a real-world, Australian cohort | Rheumatology | 2022 | 4 |
| 43 | Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group | Seminars in Arthritis and Rheumatism | 2021 | 3 |
| 44 | Use of a molecularly cloned human SS.B antigen to detect anti-SS.B antibodies | Journal of Autoimmunity | 1992 | 2 |
| 45 | Longitudinal and observational studies module | Journal of Rheumatology | 1999 | 2 |
| 46 | Stakeholder Satisfaction with the Australian Rheumatology Association Database (ARAD) | Patient | 2009 | 1 |
| 47 | β2GPI exerts an anti-obesity effect in female mice by inhibiting lipogenesis and promoting lipolysis | Oncotarget | 2017 | 1 |
| 48 | Bias, coverage, and asymptotic behaviour of random effects meta-analysis | International Journal of Evidence-Based Healthcare | 2020 | 1 |
| 49 | Comment on: Concordance between myositis autoantibodies and anti-nuclear antibody patterns in a real-world Australian cohort: reply | Rheumatology | 2022 | 1 |
| 50 | Focal myositis: an unusual cause of hip pain | Internal Medicine Journal | 2019 | 0 |
